Proteo (PTEO) 10-Q2011 Q1 Quarterly report

Filed: 13 May 11, 12:00am

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigious
Readability	H.S. freshman Bad

New words: Acidic, Agency, announced, awarded, begun, bifurcated, Biochemical, British, Cambridge, candidate, Chest, compound, Consideration, contingent, core, cost, EMA, entirety, GBP, individually, induced, influence, influenced, infrastructure, injury, intellectual, intention, judged, MHRA, NHS, nonsubstantive, overseen, partner, primary, profit, promising, QB, rare, recovery, rejection, SAE, Scotland, situation, Stroke, surgical, therapy, thromboembolic, unmet, Update, weakening, Whey

Removed: abo, accounted, acknowledged, activity, African, aggregate, aim, applied, approved, Assignee, assumption, ASU, Axel, Belgium, BfArM, blinded, btd, Bulletin, calendar, capitalized, charge, CMO, complication, concept, consented, controlled, cooperate, default, delivered, Department, devastating, disclose, Eastern, EMEA, ense, entity, Ethical, Eurogentec, evaluate, exclusively, exercising, expand, FIDEsprit, forbear, Forbearance, GmBH, goal, granting, guaranteed, Guarantor, guaranty, identify, implement, improve, Improving, Independently, Industry, infarction, initial, initially, installment, insufficient, insufficiently, Interpretation, investigated, Investor, Involved, involvement, issuance, Kutscher, lan, Lic, making, mammary, Marlene, maturing, measurement, medicinal, Middle, month, monthly, Moulton, naturally, noted, object, objective, obligated, oxygen, party, Patient, permitted, portion, post, promote, prospectively, qualified, Rabinovitch, recommending, recruiting, recruitment, region, Release, renegotiate, renowned, represented, Revised, revision, roll, Servicing, set, skin, stockholder, Subsequent, Subtopic, succeeding, successfully, sum, supply, suppressing, surrendered, technically, tissue, transfer, transferor, transplant, unpaid, unrealized, ut, validity, variable, Vera, voting, Wall, widespread

Search this filing

Filing tables

Export all tables to Excel

Filing exhibits

PTEO similar filings

Filing view

Default size S M L
Default font Times Arial

External links

Share this filing

EXHIBIT 32

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Proteo, Inc., a Nevada corporation (the "Company"), on Form 10-Q for the quarter ended March 31, 2011, as filed with the Securities and Exchange Commission (the "Report"), Birge Bargmann, Chief Executive Officer and Chief Financial Officer, does hereby certify, pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (18 U.S.C. ss. 1350), that to her knowledge:

(1)

The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2)

The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date: May 12, 2011

/s/ Birge Bargmann
Birge Bargmann
CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER

A SIGNED ORIGINAL OF THIS WRITTEN STATEMENT REQUIRED BY SECTION 906, OR OTHER DOCUMENT AUTHENTICATING, ACKNOWLEDGING, OR OTHERWISE ADOPTING THE SIGNATURE THAT APPEARS IN TYPED FORM WITHIN THE ELECTRONIC VERSION OF THIS WRITTEN STATEMENT REQUIRED BY SECTION 906, HAS BEEN PROVIDED TO PROTEO, INC. AND SUBSIDIARY AND WILL BE RETAINED BY PROTEO, INC. AND SUBSIDIARY AND FURNISHED TO THE SECURITIES AND EXCHANGE COMMISSION OR ITS STAFF UPON REQUEST.

This Certification is being furnished pursuant to Rule 15(d) and shall not be deemed “filed” for purposes of Section 18 of the Exchange Act (15 U.S.C. 78r), or otherwise subject to the liability of that section. This Certification shall not be deemed to be incorporated by reference into any filing under the Securities Act or the Exchange Act, except to the extent that the Company specifically incorporates it by reference.